RxDoctor Payments Data

Sean Gilin, MD

Family Medicine · Grand Blanc, MINPI 1811099567

Payments from drug & device makers

$6,755in general payments, 2019–2025

Across 379 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$836
  • Lilly USA, LLC$668
  • GSK$642
  • AbbVie$467
  • Amgen$449
  • Astellas Pharma US Inc$393
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$6,59498%
  • Education$1612%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,755 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$72,554
Medicare patients
144
Services billed
2,239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin106$111,475
EliquisApixaban81$110,154
OzempicSemaglutide58$96,141
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$56,560
XareltoRivaroxaban39$53,397
FarxigaDapagliflozin Propanediol23$24,438
JanuviaSitagliptin Phosphate14$21,454
InvokanaCanagliflozin11$18,512
MyrbetriqMirabegron15$13,679
MounjaroTirzepatide13$13,304
Lantus SolostarInsulin Glargine,hum.Rec.Anlog60$11,762
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$11,379
BrilintaTicagrelor19$11,077
Atorvastatin Calcium556$9,533
Celecoxib123$5,872

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$377$114,28792 claims
Boehringer IngelheimJardiance$195$111,475106 claims
Novo NordiskOzempic$836$96,14158 claims
GSKTrelegy Ellipta, Breo Ellipta$642$60,87073 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$320$46,89557 claims
MerckJanuvia$119$21,45414 claims
Astellas Pharma US IncMyrbetriq$393$13,67915 claims
Lilly USA, LLCMounjaro$668$13,30413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Grand Blanc

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →